Hypertension, endothelium, and cardiovascular risk factors
- 1 February 1991
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 90 (2) , S13-S18
- https://doi.org/10.1016/0002-9343(91)90029-w
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Integrated cardiac, renal, and endocrine actions of endothelin.Journal of Clinical Investigation, 1989
- Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytesBiochemical and Biophysical Research Communications, 1988
- Endothelium-derived contracting factor: endothelin and/or superoxide anion?Trends in Pharmacological Sciences, 1988
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology, 1987
- Modulation of Vascular Smooth Muscle Contraction by the EndotheliumAnnual Review of Physiology, 1986
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980